Diabetes and endocrinology
Diabetes drugs found to lower risk of dementia in large analysis
Engage with pharmacy teams on major conditions, leaders urge government
Government pauses work on ‘major conditions’ strategy
One third of ‘soups and shakes’ programme finishers in type 2 diabetes remission
Statin tops NHS prescribing once again as total number of items continues to increase
‘Soup and shakes’ diet programme being rolled out across England
Semaglutide helps heart failure symptoms in patients with obesity and type 2 diabetes
GLP-1 receptor agonists not linked to suicidal thoughts, PRAC concludes
Diabetes drug shows potential in treating Parkinson’s disease
Notification issued for multiple GLP1-RA shortages
Supporting patients with diabetes during Ramadan fasting
Long-term type 2 diabetes remission through weight loss ‘unsustainable’ for most
Mounjaro weight loss service hoped to ease supply issues
Exercise reduces risk of kidney disease in patients with type 2 diabetes
Government extends GLP-1 RA shortage warning until end of 2024
NICE recommends ‘game changer’ wearable tech for type 1 diabetes
Study finds potential for weekly insulin injections in diabetes care
MHRA finds fake Ozempic pens in UK supply chain
PCN to use conversation app to improve medicines adherence
Tirzepatide approval sparks hope though supply warnings remain
More Stories
